Table 1.
Patient Baseline Characteristics.
| Variable | Robotic-Assisted Proctectomy with IPAA (n = 29) |
Laparoscopic Proctectomy with IPAA (n = 38) | p Value |
|---|---|---|---|
| Age, Mean ± SD, years | 39 ± 15 | 37 ± 12 | 0.704 |
| ASA classification, No. (%) | 0.454 | ||
| 1, Normal healthy patient | 3 (10.3) | 5 (13.2) | |
| 2, Patient with mild systemic disease | 21 (72.4) | 30 (78.9) | |
| 3, Patient with severe systemic disease | 5 (17.2) | 3 (7.9) | |
| Sex, No. (%) | 0.624 | ||
| Female | 16 (55.2) | 18 (47.4) | |
| Male | 13 (44.8) | 20 (52.6) | |
| BMI a, Mean ± SD, kg/m2 | 24.0 ± 4.0 | 23.7 ± 4.6 | 0.699 |
| Previous abdominal surgeries, No. (%) | 0.028 * | ||
| 1 | 15 (51.7) | 30 (78.9) | |
| 2–3 | 14 (48.3) | 8 (21.1) | |
| Current smoking, No. (%) | 2 (6.9) | 0 (0.0) | 0.184 |
| Diabetes, No. (%) | 1 (3.4) | 1 (2.6) | 1.000 |
| Anemia, No. (%) | 0 (0.0) | 2 (5.3) | 0.502 |
| Preoperative steroid use, No. (%) | 1 (3.4) | 2 (5.3) | 1.000 |
| Preoperative immunomodulatory use, No. (%) | 0 (0.0) | 2 (5.3) | 0.502 |
Data are presented as n (%) or mean ± SD; bold characters indicate significant values, * p ≤ 0.05; immunomodulatories including methotrexate, azathioprine, and biologicals. Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); IPAA, ileal pouch-anal anastomosis; SD, standard deviation. a Derived from the World Health Organization classification of obesity based on BMI, with a BMI of 25.0–29.9 indicating overweight and a BMI of 30.0 or greater indicating obesity.